| Ytd | -91.31% | |
| 1y | -97.70% |
| Open | 0.37 | Prev Close | 0.36 | Low | 0.36 | High | 0.37 | Mkt Cap | 3.38M |
| Vol | 136.77K | Avg Vol | 589.22K | EPS | -5.62 | P/E | N/A | Forward P/E | -2.57 |
| Beta | 3.66 | Short Ratio | 0.35 | Inst. Own | 10.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-23 | 50-d Avg | 0.70 | 200-d Avg | 2.16 | 1yr Est | 14.60 |
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark
Noble Capital Markets analyst Robert LeBoyer maintains Geovax Labs (NASDAQ:GOVX) with a Outperfor
Gainers Aardvark Therapeutics (NASDAQ:AARD) shares increased by 8.5% to $6.28 during Friday's a
https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidem
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.97) per share which beat the analyst cons
GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Foc
Estee Lauder (EL) shares jumped 11.8% in pre-market trading after ending discussions with Puig. Othe
GeoVax Labs, Inc. (NASDAQ:GOVX), a clinical-stage biotech company, is trading higher on Wednesday as
GeoVax shares gain after the company highlighted its MVA vaccine platform's potential against Eb
https://geovax.com/investors/press-releases/geovax-comments-on-escalating-bundibugyo-ebola-outbreak-
GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement,
https://x.com/PatentGrants/status/2056464996494880918
Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is refl
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(2.62) per share which beat the analyst cons
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintai
On January 9, 2026, GeoVax Labs, Inc. (the "Company" or "we") filed a Certificate of
GeoVax Labs Inc. (NASDAQ: GOVX - Get Free Report) was up 21.1% on Friday. The company traded as high
GEOVAX LABS, INC. 18,292,683 Common UnitsEach Common Unit Consisting ofOne Share of Common Stock and
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and lowers
GeoVax Labs, Inc. ( GOVX ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.31) per share which missed the analyst co
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ: GOVX) with a Buy and mainta
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is refl
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintai
D. Boral Capital analyst Jason Kolbert maintains Geovax Labs (NASDAQ:GOVX) with a Buy and maintai
GeoVax Labs Revenue Doubles in Q2
GeoVax Labs, Inc. (NASDAQ:GOVX ) Q2 2025 Earnings Conference Call July 28, 2025 4:30 PM ET Company P
Geovax Labs (NASDAQ:GOVX) reported quarterly losses of $(0.35) per share which beat the analyst cons